A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model by Martin, F-PJ et al.
A top-down systems biology view of microbiome-
mammalian metabolic interactions in a mouse model
Franc¸ois-Pierre J Martin1,2, Marc-Emmanuel Dumas1, Yulan Wang1, Cristina Legido-Quigley1, Ivan KS Yap1, Huiru Tang1,3,
Se´verine Zirah1,4, Gerard M Murphy1, Olivier Cloarec1, John C Lindon1, Norbert Sprenger2, Laurent B Fay2, Sunil Kochhar2,
Peter van Bladeren2, Elaine Holmes1 and Jeremy K Nicholson1,*
1 Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Faculty of Medicine, Imperial College London,
South Kensington, London, UK and 2 Nestle´ Research Center, Vers-chez-les-Blanc, Lausanne, Switzerland
3 Present address: State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Centre for Magnetic Resonance, Wuhan Institute
of Physics and Mathematics, The Chinese Academy of Sciences, Wuhan 430071, PR China
4 Present address: Regulations, Development and Molecular Diversity, National Museum of Natural History, Paris 75005, France
* Corresponding author. Department of Biomolecular Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Faculty of Medicine, Imperial
College London, Sir Alexander Fleming Building, Exhibition road, South Kensington, London SW7 2AZ, UK. Tel.: þ 44 20 7594 3195; Fax: þ 44 20 7594 3226;
E-mail: j.nicholson@imperial.ac.uk
Received 5.2.07; accepted 14.3.07
Symbiotic gut microorganisms (microbiome) interact closely with the mammalian host’s
metabolism and are important determinants of human health. Here, we decipher the complex
metabolic effects of microbial manipulation, by comparing germfree mice colonized by a human
baby flora (HBF) or a normal flora to conventional mice. We perform parallel microbiological
profiling, metabolic profiling by 1H nuclear magnetic resonance of liver, plasma, urine and ileal
flushes, and targeted profiling of bile acids by ultra performance liquid chromatography–mass
spectrometry and short-chain fatty acids in cecum by GC-FID. Top-down multivariate analysis of
metabolic profiles reveals a significant association of specific metabotypes with the resident
microbiome. We derive a transgenomic graph model showing that HBF flora has a remarkably
simple microbiome/metabolome correlation network, impacting directly on the host’s ability to
metabolize lipids: HBF mice present higher ileal concentrations of tauro-conjugated bile acids,
reduced plasma levels of lipoproteins but higher hepatic triglyceride content associated with
depletion of glutathione. These data indicate that the microbiome modulates absorption, storage and
the energy harvest from the diet at the systems level.
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Introduction
The symbiotic gut microbiome exerts a strong influence on the
metabolic phenotype of the mammalian host and participates
in extensive microbial–mammalian co-metabolism (Dunne,
2001; Xu and Gordon, 2003; Backhed et al, 2005; Eckburg et al,
2005; Holmes and Nicholson, 2005; Nicholson et al, 2005; Gill
et al, 2006; Martin et al, 2006; Nicholson, 2006; Turnbaugh
et al, 2006). Gut microbial composition is now known to vary
significantly in obese animal (Turnbaugh et al, 2006) and
human (Ley et al, 2006) populations, and recent studies have
shown that the exact state of the gut microbial ecology and
metabolic activities may be of fundamental importance in the
control of calorific absorption (Xu et al, 2003; Backhed et al,
2004) and in the development of insulin resistance and
nonalcoholic fatty liver disease in high-fat-diet experiments
(Dumas et al, 2006). We know that the symbiotic gut
microbiome acts as an extended genome (Lederberg, 2000)
and has evolved to exert control on a number of important
mammalian metabolic regulatory functions (Dunne, 2001;
Pereira and Gibson, 2002; Xu and Gordon, 2003; Xu et al,
2003; Backhed et al, 2004, 2005; Holmes and Nicholson, 2005;
Nicholson et al, 2005; Dumas et al, 2006; Gill et al, 2006; Martin
et al, 2006; Sonnenburg et al, 2006). Gut microbes extensively
co-metabolize bile acids and these have mammalian endocrine
functions (Houten et al, 2006; Watanabe et al, 2006).
The integrated metabolism of the bile acid pools in
mammals is a good example of the complex transgenomic
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biochemical interactions between host and microbiome
symbionts as summarized in Figure 1. Bile acids are
synthesized from cholesterol in the liver by a multi-enzyme
coordinated process (Palmeira and Rolo, 2004) and are crucial
for the absorption of dietary fats and lipid-soluble vitamins in
the intestine (Staggers et al, 1982). Bile acids also have a role in
maintaining the intestinal barrier function to prevent intestinal
bacterial overgrowth and translocation (Lorenzo-Zuniga et al,
2003; Ogata et al, 2003), as well as invasion of underlying
tissues by enteric bacteria (Ogata et al, 2003). In addition,
abnormal bile acid profiles are indicative of various hepato-
gastrointestinal diseases, such as dietary fat malabsorption
and gallstone formation (Chace, 2001; Ijare et al, 2005) and
might have an essential role in regulating obesity or type II
diabetes (Houten et al, 2006; Watanabe et al, 2006). Many
so-called secondary bile acids (deoxycholic, lithocholic,
hyodeoxycholic and o-muricholic acids) can be regarded
as examples of mammalian-microbiotal co-metabolism
(Nicholson et al, 2005) and have different metabolic fates
via enterohepatic recirculation (Nicholson et al, 2004). This is
part of what we term the microbiome–host metabolic axis,
which we define here for the first time as ‘the multi-way
exchange and co-metabolism of compounds between the host
organism and the gut microbiome resulting in transgenomi-
cally regulated secondary metabolites, which have biological
activity in both host and microbial compartments’. Under-
standing the effects of bacterial metabolism on the balance of
bile acids in enterohepatic recirculation is a major challenge
owing to the implications of microbiota in fat absorption, lipid
metabolism, drug therapeutic or toxic effects as well as direct
effects within the gastrointestinal tract and its contents (Van
et al, 2002). In this regard, recent advances in microbial and
metabolic profiling now enable the multi-compartment study
of bile acids and their effect on intermediary metabolism.
The application of high-resolution 1H nuclear magnetic
resonance (NMR) spectroscopy of biofluids and tissues
coupled with multivariate statistical methods is a well-
established tool for untargeted metabolic profiling (Nicholson
and Wilson, 1989; Nicholson et al, 2002, 2005; Wang et al,
2005). Hyphenated chromatographic-mass spectrometric
methods such as ultra-performance liquid chromatography–
mass spectrometry (UPLC–MS)-based profiling techniques
have also been recently used effectively for functional genomic
discrimination (Plumb et al, 2005; Wilson et al, 2005). Lately,
LC–MS has been shown to be a sensitive and quantitative
method of analysis for identification of major bile acids in
urine and plasma (Mims and Hercules, 2003, 2004). Histori-
cally, bile acid analysis has been hindered by difficulties in
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Figure 1 Metabolism and synthesis of the major bile acids in mouse. Key: Color denotes family of bile acids, that is, primary bile acids synthesized in liver in black,
secondary bile acids synthesized in liver and processed by microflora in green and tertiary bile acids synthesized in liver, processed by microflora and re-metabolized in
liver through enterohepatic recirculation in orange. Conjugation with taurine and glycine is colored in blue and red respectively. Key intermediates in the pathway are
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Microbiome–mammalian metabolic interactions
F-PJ Martin et al
2 Molecular Systems Biology 2007 & 2007 EMBO and Nature Publishing Group
separating many structurally similar compounds and isomers
in a highly complex matrix. We have now developed and show
here for the first time an enhanced bile-acid-targeted profiling
method using UPLC–MS, which gives superior chromato-
graphic resolution and sensitivity (Wilson et al, 2005; Plumb
et al, 2006) and greatly aids the study of bile acid metabolism.
In the present study, the complex metabolic response of the
host to perturbation of its enteric microbiota at the systems
level by integration of metabolic data from many compart-
ments was investigated. The aim of the study is to assess the
effects of the induction of a nonadapted microflora in a murine
model (human baby flora (HBF)) on the host metabolism
by comparison with animals colonized with a natural
gut microflora (conventional), the result of a long period of
co-evolution. An additional group of germfree mice, naturally
re-conventionalized, was used as a control to investigate the
specific effects related to the re-establishment of a flora in
previously germfree mice. Here, we have integrated the effects
of modulation of the microbiome in mouse models on major
bile acids co-metabolism through targeted metabolic profiling,
and characterized the consequences of this intervention at the
systems level through parallel untargeted metabolic profiling,
multivariate and graph modeling. Here, we show a significant
association of specific metabotypes and changes of the gut
microbiome between mice colonized naturally with a conven-
tional microflora or colonized with a defined microbial
population derived from human host in a pathogen-free
environment, that is, HBF. This study brings further evidence
that gut microflora is adapted to each host and that gut
microflora influences the host’s systemic lipid metabolism and
energy balance through modification of bile acid metabolism
and eventually impacts on the host’s health.
Results
Gut bacterial composition and fecal content
of short-chain fatty acids
Microbiological profiles were used to assess the stage of bacterial
development during re-conventionalization and colonization
with an HBF. The terminal composition of the fecal microbiota
is detailed in Table I. Using a two-tailed Mann–Whitney test,
we showed that after 32 days of natural re-conventionalization,
the mice have similar microbial composition in feces as con-
ventional animals, although their levels of Bacteroides and
Enterobacteria were higher (Table I). The HBF mice had
markedly different gut microbiota characterized by an important
population of Clostridium and higher levels of Bacteroides and
Enterobacteria as those observed in re-conventionalized mice
when compared to conventional mice (Table I).
The fecal content of individual animals was investigated
using gas-chromatography–flame-ionization-detection (GC–
FID) to identify and quantify some major bacterial short-chain
fatty acids (SCFAs), namely acetate, propionate, isobutyrate,
n-butyrate, n-valerate and isovalerate. Although lactate
changes were expected, they were not in fact measured. The
results presented in Table II are given in mmol/g of dry fecal
content, and as mean7s.d. for each group of mice, and were
assessed using a two-tailed Mann–Whitney test. The produc-
tion of SCFAs by the gut microbiota of re-conventionalized
mice was similar to that of conventional mice, except that the
latter has higher levels of acetate. These SCFAs were found in
lower concentrations and in different proportions in HBF mice
(Table II). In particular, a higher proportion of propionate
(24.574%) and a lower proportion of n-butyrate (4.273.4%)
were observed in HBF mice (controls were 10.271.2 and
11.173.4%, respectively).
1H NMR spectroscopy of mouse plasma, urine,
liver and ileal flushes
Examples of typical 1H NMR spectra of urine, 1H CPMG NMR
spectra of liver and plasma from an HBF mouse, and 1H NMR
spectra of ileal flushes from HBF and conventional mice are
shown in Figure 2 and were assigned according to literature
(Nicholson et al, 1995; Tugnoli et al, 2004; Wang et al, 2005),
and confirmed by selected 1H-1H correlation spectroscopy
Table I Microbial species counts in mouse feces at the end of the experiment
Groups/
log10 CFU
Conventional
(N¼10)
Re-conventional
(N¼10)
HBF-L. paracasei
(N¼7)
Lactobacilli 6.471.5 5.972.5 7.170.4
Enterobacteria 6.571.0 7.870.7** 9.170.4***a
Bifidobacteria 7.071.2 7.871.4 7.570.7
Staphylococcus 4.870.7 4.771.0 5.870.4
C. perfringens o2 o2 7.070.9***a
Bacteroides 8.370.4 9.170.6** 9.570.9***
Log10 of CFU (colony-forming unit) given per gram of wet weight of feces. Data
are presented as mean7s.d. The average values for the re-colonized group were
compared to the conventional animals: *significant difference at 95%
confidence level, **significant difference at 99% confidence level, ***signifi-
cant difference at 99.9% confidence level.
aSignificant difference at 99.9% confidence level was observed when compared
to the re-conventionalized animals.
Table II Short-chain fatty acid content in the cecum from the different groups
SCFAs\microbiota Acetate Propionate Isobutyrate Butyrate Isovalerate Valerate
Conventional 179.1743.5
(73.773.5)
24.475.3
(10.271.2)
3.170.5
(1.370.2)
27.1711.7
(11.174.3)
4.771.3
(270.4)
4.271
(1.770.4)
Re-conventional 136.6751.4*
(6774.2**)
26.576.4
(14.573.7***)
3.370.8
(1.770.4**)
27.5713
(12.174.3)
4.671.2
(2.570.8)
4.571.2
(2.270.5*)
HBF-L. paracasei 34.479.9***
(65.973.1***)
12.874***
(24.574***)
0.670.1***
(1.270.3**)
1.970.9***
(4.273.4***)
1.770.9***
(3.371.4***)
0.470.1***
(0.970.5**)
Data are presented in mmol/g of dry feces and are presented as means7s.d. The relative composition in short-chain fatty acids in percentage of total content. The
average values for the re-colonized group were compared to the conventional animals: *significant difference at 95% confidence level, **significant difference at 99%
confidence level, ***significant difference at 99.9% confidence level.
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(COSY) (Hurd, 1990) and 1H-1H total correlation spectroscopy
(TOCSY) (Bax and Davis, 1985) two-dimensional (2D) NMR
experiments on single sample as well as selective statistical
total correlation spectroscopy (STOCSY) (Cloarec et al, 2005a)
experiments on multiple samples. In particular, NMR spectro-
scopy detects a wide range of amino acids, metabolism
intermediates, organic acids, membrane components, satu-
rated and unsaturated triglycerides and fatty acids, ketone
bodies, N-acetyl and O-acetyl-glycoproteins (Table III). Indo-
leacetylglycine (IAG), phenylacetylglycine (PAG), trimethyl-
amine (TMA), trimethylamine-N-oxide (TMAO) and dimethyl-
glycine (DMG) were also identified in urine. Using NMR, five
bile acid species were assigned unambiguously in ileal flushes,
that is, b-muricholic (bMCA), tauro-b-muricholic (TbMCA),
cholic (CA), taurocholic (TCA) and tauroursodeoxicholic
(TUDCA) acids. 1H NMR spectra of pure compound showed
that the 1H NMR chemical shifts of C-18, C-19 and C-21 methyl
groups were characteristic for the determination of indivi-
dual bile acid levels. However, this method is of limited
use for probing complex mixtures and for differentiating
conjugated from unconjugated forms of bile acids in such
mixtures.
1H NMR spectral complementary data sets from plasma,
urine, liver tissue or ileal flushes were analyzed using
orthogonal partial least squares discriminant models
(O-PLS-DA) (Trygg and Wold, 2003) to maximize the discrimi-
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Figure 2 Typical 600 MHz 1H NMR spectra. 1H CPMG NMR spectra of plasma (A) and intact liver tissue (B), and 1H NMR spectrum of urine (C) from an HBF mouse,
and 1H NMR spectra of ileal flushes from HBF (D) and conventional mice (E). The spectra of the urine and ileal flushes were magnified 6 and 10 times respectively in the
aromatic region (d 5.2–8.5) compared to the aliphatic region (d 0.7–4.5). The liver regions d 5.2–5.4 and 5.4–8.5 were magnified 4 and 8 times respectively. The plasma
regions d 5.2–5.4 and 5.4–8.5 were magnified 4 and 10 times respectively. Keys to the figures are given in Table III.
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nation of experimental groups and focus on metabolic variations
explained to gut flora changes (Figure 3). The characteristics of
the models generated are summarized in Table IV. O-PLS-DA
revealed significant variations in the metabolic profiles
from plasma, liver and urine between conventional and
re-conventionalized animals (Table IV). Re-conventionalized
Table III Table of assignment of the metabolites in plasma, liver, urine and ileal flushes
Key Metabolites Moieties d 1H (p.p.m.) and multiplicity
1 Isoleucine aCH, bCH, gCH3, dCH3 3.65(d), 1.95(m), 0.99(t), 1.02(d)
2 Leucine aCH, bCH2, dCH3, dCH3 3.72(t), 1.96(m), 0.91(d), 0.94(d)
3 Valine aCH, bCH, gCH3 3.6(d), 2.26(m), 0.98(d), 1.04(d)
4 Ethanol CH2, bCH3 3.65(q), 1.18(t)
5 3-D-hydroxybutyrate CH, CH2, gCH3, CH2 4.16(dt), 2.41(dd), 1.20(d), 2.31(dd)
6 Lactate aCH, bCH3 4.11(q), 1.32(d)
7 Alanine aCH, bCH3 3.77(q), 1.47(d)
8 Arginine aCH, bCH2, gCH2, dCH2 3.76(t), 1.89(m), 1.63(m), 3.23(t)
9 Lysine aCH, bCH2, gCH2, dCH2, eCH2 3.77(t), 1.89(m), 1.72(m), 1.47(m), 3.01(t)
10 Acetate CH3 1.91(s)
11 Threonine aCH, bCH2, gCH3 3.59(d), 4.25(m), 1.32(d)
12 Proline aCH, bCH2, gCH2, dCH2 4.11(t), 2.02(m)–2.33(m), 2.00(m), 3.34(t)
13 Glutamate aCH, bCH2, gCH2 3.75(m), 2.08(m), 2.34(m)
14 Methionine aCH, bCH2, gCH2, dCH3 3.78(m), 2.14(m), 2.6(dd), 2.13(s)
15 Lipids CH3, (CH2)n, CH2-C¼C, CH2-C¼O,
¼C-CH2-C¼, -CH¼CH-
0.89(m), 1.27(m), 2.0 (m), 2.3(m), 2.78(m), 5.3(m)
16 Glutamine aCH, bCH2, gCH2 3.77(m), 2.15(m), 2.44(m)
17 Citrate CH2(2), CH2(1) 2.55(d), 2.65(d)
18 Pyruvate CH3 2.41(s)
19 Aspartic acid aCH, bCH2 3.89(m), 2.68(m), 2.82(m)
20 Asparagine aCH, bCH2 3.90(m), 2.86(m) 2.94(m)
21 Creatine N-CH3, CH2 3.03(s), 3.92(s)
22 Glutathione CH2, CH2, S-CH2, N-CH, CH 2.17(m), 2.55(m), 2.95(m), 3.83(m), 4.56(m),
23 Choline N-(CH3)3, OCH2, NCH2 3.2(s), 4.05(t), 3.51(t)
24 Phosphorylcholine N(CH3)3, OCH2, NCH2 3.22(s), 4.21(t), 3.61(t)
25 GPC N-(CH3)3, OCH2, NCH2 3.22(s), 4.32(t), 3.68(t)
26 Taurine N-CH2, S-CH2 3.26(t), 3.40(t)
27 Glycine CH2 3.55(s)
28 N-acetyl-glycoproteins
(Nac)
CH3 2.04(s)
29 O-acetyl-glycoproteins CH3 2.08(s)
30 Trimethylamine-N-oxide
(TMAO)
CH3 3.26(s)
31 Tyrosine CH, CH 7.16(dd), 6.87(dd)
32 Phenylalanine 2,6-CH, 3,5-CH, 4-CH 7.40(m), 7.33(m), 7.35(m)
33 Tryptamine 4-CH, 7-CH, 2-CH, 6-CH, 5-CH, CH2, CH2 7.70(d), 7.52(d), 7.34(s) 7.29(t), 7.21(t), 3.35(t), 3.18(t)
34 Glycogen Ring protons, CH 3.35–4.0(m), 5.38–5.45(m)
35 a-Glucose 1-CH 5.24(d)
36 Scyllo-inositol OH 3.34(s)
37 Indoleacetyl-glycine (IAG) 4-CH, 7-CH, 2-CH, 5-CH, 6-CH, CH2, CH2 7.64(d), 7.55(d), 7.35(s) 7.28(t), 7.19(t), 3.82(s), 3.73(s)
38 Phenylacetyl-glycine (PAG) 2,6-CH, 3,5-CH, 7-CH, 10-CH 7.43(m), 7.37(m), 3.75(d), 3.68(s)
39 3-Hydroxy-isovalerate CH3 1.21(s)
40 Creatinine CH3, CH2 3.06(s), 4.06(s)
41 Phosphocreatine CH3, CH2 3.05(s), 3.95(s)
42 Isobutyrate CH3, CH 1.11(d), 3.02(m)
43 a-Ketoisovalerate CH3, CH 1.13(d), 3.02(m)
44 Butyrate CH3, CH2, CH2 0.90(t), 2.16(t), 1.56(m)
45 a-Keto-isocaproate CH3, CH, CH2 0.94(d), 2.10(m), 2.61(d)
46 Kynurenine CH, CH, CH, CH, CH, CH 4.16(t), 3.72(d), 7,89(d), 6.82(t), 7.43(t), 6.89(d)
47 Uridine CH, CH, CH, CH, CH, CH, CH2, CH2 7.87(d), 5.92(d), 5.9(s), 4.36(t), 4.24(t), 4.14(q), 3.92(dd),
3.81(dd)
48 Formate CH 8.45(s)
49 Fumarate CH 6.53(s)
50 Citrulline CH, CH2, CH2, CH2 3.76(t), 3.15(q), 1.88(m), 1.52(m)
51 2-Oxoglutarate CH2, CH2 3.01(t), 2.45(t)
52 b-Alanine CH2, CH2 3.19(t), 2.56(t)
53 Dimethylglycine (DMG) CH2 2.93(s)
54 Trimethylamine (TMA) CH3 2.91(s)
55 Inosine 2-CH, 8-CH, 20-CH, 40-CH, 50-CH, CH2, CH2 8.34(s), 8.24(s), 6.1(d), 4.44(t), 4.28(q), 3.92(dd), 3.85(dd)
56 Putative glycolipid (U1) CH3, CH2, — 0.89(m), 1.27(m), 1.56(m), 1.68(m), 2.15(m), 2.25(m),
3.10(m), 3.55(m), 3.60(m)
57 p-Toluyl derivative (U2) CH3, CH2, CH2, CH2 2.38(s), 7.31(d), 7.26(d), 5.42(m)
58 Unknown (U3) — 0.37(t), 0.66(m), 0.74(m), 0.90(m), 1.15(m), 1.35(m), 2.24(m)
59 Unknown (U4) — 3.49(s), 1.14(d)
60 Glycerol C2-H, CH2, CH2 3.91(m), 3.64(m), 3.56(m)
s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublet; dt, doublet of triplet.
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mice had higher levels of plasma GPC and choline, lower
urinary concentrations of guanidinoacetate and lower levels of
liver glycogen (data not shown).
Significant and predictive discrimination of plasma, liver,
urine and ileal flushes between conventional and HBF mice
was achieved using O-PLS-DA, as denoted by high Q2Y values
(Table IV). The corresponding coefficient plots show the
key metabolites in plasma, liver, urine and ileal flushes
that contribute to the separation (Figure 3). Decreases in
levels of lipoproteins and pyruvate, and increased levels of
GPC, choline, acetate and glutamine were observed in the
plasma of HBF mice when compared to conventional animals
(Figure 3A and Supplementary Figure 1). The liver of HBF
mice also showed higher levels of triglycerides and lower
concentrations of glycogen, lysine, arginine, asparagine,
aspartate, glutamine and glutathione (Figure 3B and Supple-
mentary Figure 1). Urinary profiles of HBF mice showed lower
levels of PAG, tryptamine and an unknown metabolite (U1),
and higher levels of b-alanine, 3-hydroxy-isovalerate, N-acetyl
signals from glycoproteins and a putative glycolipid as
discussed earlier (Figure 3C). Differences in the ileal flushes
were also characterized with higher levels of TbMCA and
lower levels of CA and TUDCA (Figure 3D).
UPLC–MS analysis and ileal content in bile acids
To complement the bile acid profiling achieved by NMR, we
also analyzed ileal flushes using UPLC–MS. Typical negative
ion chromatograms for the bile acids detected in the ileal flush
of a conventional mouse are shown in Figure 4. A total of 14
bile acids were identified by comparison with a series of 22 bile
acid standards. Three additional bile acid components,
identified as U1 (m/z¼453.2, RT¼2.70), U2 (m/z¼437.2,
RT¼4.44) and U3 (m/z¼491.2, RT¼1.53), were also observed.
Unconjugated muricholic and cholic acids with mass to charge
ratio of m/z¼408.2 were detected at m/z¼453.2 due to the
formation of a formate adduct (45 Da).
The relative bile acid compositions in ileal flushes from the
different groups are given in Table V, and are shown as
mean7s.d. of the percentage of the total bile acid content.
UPLC–MS analysis showed that conventional and re-conven-
tionalized mice had specific bile acid profiles—14 bile acids
were identified, the most abundant species being CA, TCA,
TbMCA and TUDCA. HBF animals showed lower diversity in
their bile acid composition, predominantly containing TbMCA
and TCA as well as CA, aMCA, bMCA, TCDCA, TUDCA and
putative unknown bile acid U3.
A comparison of concentrations of bile acids obtained from
HBF re-colonized mice with those from conventional mice
using an O-PLS-DA strategy revealed that conventional mice
showed lower amounts of taurine conjugates such as TbMCA
and TCA, and a higher amount of CA, which is in agreement
with the observations obtained by 1H NMR spectroscopy
(Figure 5A). Aweak discrimination was also obtained between
conventional and re-conventionalized animals (Figure 5B),
with the latter showing lower levels of CDCA and GCA, and
higher concentrations of TbMCA.
Effect of major bile acids on tissue-specific
metabolic profiles
The effect of TCA and CA on the enterohepatic recirculation
was assessed by OPLS regression, using the NMR-based
metabolic profiles from intact liver tissues and ileal luminal
content as X input and CA (or TCA) levels obtained by UPLC–
MS as Y (Figure 6). The 1H NMR metabolic profiles obtained
from ileal flushes (Figure 6B and D) show a marked
anticorrelation between TCA and CA, these two major bile
acids operating as ‘anchor’ metabolites. There is a positive
correlation between conjugated taurine and taurine-conju-
gated bile acids, that is, TCA and TbMCA. This cluster of
conjugated species is anticorrelated to free species, that is, CA
and free taurine, consistent with a bacterial deconjugation of
bile acids in the ileum. In the liver (Figure 6A and C), the
situation is reversed, with TCA (CA) being correlated (anti-
correlated) with free taurine, highlighting the fact that the
conjugation process is restricted by the available amount of
taurine (substrate).
Integration of correlations between bile acids
and fecal flora
A novel correlative analysis was performed to investigate the
cross-compartment connections between fecal flora and bile
acids in the intestinal lumen. Bipartite graphs were used to
visualize correlations (above a given cutoff) between fecal
bacteria and bile acids (see Materials and methods and
Figure 7). Conventional and HBF mice show very different
bile acid/fecal flora correlation networks (Figure 7A and B).
Figure 3 O-PLS-DA coefficient plots derived from 1H NMR spectra. O-PLS-DA coefficient plots derived from 1H NMR CPMG spectra of plasma (A), 1H MAS NMR
CPMG spectra of liver (B) and 1H NMR spectra of urine (C) and ileal flushes (D) indicating discrimination between conventional (negative) and HBF-colonized mice
(positive). The O-PLS-DA coefficient plots are presented using a back-scaling transformation, as described previously (Cloarec et al, 2005b), which allows each variable
to be plotted with a color code that relates to the significance of class discrimination as calculated from the correlation matrix. Arg, arginine; Asp, aspartate; Asn,
asparagine; CA, cholic acid; Gln, glutamine; Gsh, glutathione; GPC, glycerophosphorylcholine; IAG, indoleacetylglycine; Lys, lysine; Nac, N-acetyl-glycoproteins; PAG,
phenylacetylglycine; TCA, taurocholic acid; TbMCA, Tauro b muricholic acid; TUDCA, tauroursodeoxycholic acid.
Table IV O-PLS-DA model summary for discriminating NMR spectra of plasma,
urine, liver and ileal flushes
Discrimination
analyzed/sample
Conventional versus
re-conventionalized
Conventional versus
HBF
Plasma Q2Y¼29%, R2X¼23% Q2Y¼70%, R2X¼28%
Urine Q2Y¼40%, R2X¼37% Q2Y¼75%, R2X¼44%
Liver Q2Y¼42%, R2X¼54% Q2Y¼46%, R2X¼54%
Ileal flushes Q2Yo0 Q2Y¼35%, R2X¼84%
O-PLS models were generated with (1) predictive component and (2) orthogonal
components to discriminate between two groups of mice. The R2X value shows
how much of the variation in the data set X is explained by the model. The Q2Y
value represents the predictability of the models and relates to its statistical
validity. A negative value indicates that differences between groups are
statistically nonsignificant.
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Figure 4 Structural and functional study of bile acids. Structures of bile acids and cholesterol (A), as characterized in this study. Color denotes family of bile acids, that
is, primary (black), secondary (green) and tertiary (orange). Conjugation with taurine and glycine is colored in blue and red respectively. Key intermediates in the pathway
are colored in gray. Typical negative ion mass chromatograms from the UPLC–MS analysis (B) for the ions detected at the given m/z for the ileal flush from
a conventional mouse with sample injections of 10 ml (1ml for m/z¼514.2). Numbers under the m/z ratios are the total ion counts for that chromatogram.
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Network statistics given for several correlation cutoffs
(Figure 7C) reveal that microbiome/metabolome bipartite
graphs from HBF mice show in general lower complexity than
conventional mice. In particular, for |r|40.5, we observed that
in the conventional flora network of degree 9, the most
connected bacteria are Lactobacilli (correlated to nine different
bile acids, Figure 7A). HBF mice are supplemented with one
Lactobacillus strain (Lactobacillus paracasei) for which only
one functional correlation is significant, whereas the most
connected bacteria are Enterobacteria (Escherichia coli)
(correlated to three bile acids; Figure 7B).
Discussion
We have investigated the host’s metabolic response to
perturbation of its enteric microbiota at the systems level,
using multiple compartment information deriving from ‘state-
of-the-art’ metabolic profiling technologies combined with
novel data analysis methods. A significant association
between changes of the gut microbiome and specific metabo-
types (obtained from urine, plasma, intact liver tissue and ileal
flush) in mice was shown. This study brings further evidence
that gut microbiota modulates the host systemic lipid
metabolism through (i) modification of bile acid metabolic
patterns, impacting directly on (ii) emulsification and absorp-
tion properties of bile acids and then indirectly on (iii) storage
of fatty acids in liver and (iv) lipoperoxidation through bile
acid signaling properties, as detailed below (Figure 8).
Modulation of bile acid conjugative patterns
by gut microbiota
The various properties of bile acids provide a complex
signaling system in which the gut microflora finely interacts
with the host’s metabolism. Previous analyses in rodents
(Floch, 2002) reported that the liver secretes almost 100%
tauro-conjugated bile acids in the bile (typically 60% TbMCA
Table V Bile acids composition in gut flushes for the different microbiota
Microbiota/bile acids Conventional Re-conventional HBF
DCA 0.770.5 171 ND
CDCA 0.570.1 0.270.1 ND
UDCA 0.570.2 0.770.6 ND
CA 17.776.7 12.779.1 0.470.5
oMCA 0.871 0.770.5 ND
aMCA 0.970.7 0.670.5 0.370.2
bMCA 1.671 1.971.4 0.970.7
HCA 0.170.1 0.170.1 ND
GCA 0.370.1 0.170.1 ND
TDCA 0.770.4 0.670.6 ND
TCDCA 1.971.3 1.170.6 3.371
TUDCA 5.572.3 4.770.8 6.671.4
TbMCA 42.674.2 52.477.6 49.674.8
TCA 23.2713.3 22719.4 3873.4
Ratio TCA:CA 1.4 1.7 118.8
Ratio TbMCA:bMCA 24.0 27.7 52.0
NB: Relative composition in bile acids given in percentage of total bile acid
content. Species not detected with UPLC-MS experiment are shown as ND.
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Figure 5 O-PLS-DA coefficient plots derived from the UPLC–MS bile acid composition. O-PLS-DA coefficient plots derived from the bile acid composition obtained by
UPLC–MS analysis of ileal flushes, indicating discrimination between conventional (positive) and HBF colonized mice (negative) (A), and partial discrimination between
conventional (positive) and re-conventionalized mice (negative) (B). The color code corresponds to the correlation coefficients of the variables. One predictive and one
orthogonal components were calculated, and the respective (Q2Y, R2X) are (89.1%, 80%) and (51.4%, 62%). The O-PLS-DA coefficient plots are presented using
a back-scaling transformation, as described previously (Cloarec et al, 2005b), which allows each variable to be plotted with a color code that relates to the significance
of class discrimination as calculated from the correlation matrix.
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and 40% TCA). In our study on conventional and re-
conventionalized mice, primary, secondary and tertiary bile
acids are observed as unconjugated, tauro- and glyco-
conjugated species ileal flushes (Table V). These observations
illustrate the ability of ‘healthy and normal’ gut microbiota
(Hooper and Gordon, 2001) to deconjugate bile acids and
modify them as detailed in Figure 1 and previously (De Smet
et al, 1998; Ridlon et al, 2006). The bacterial composition of
HBF implemented in a murine gastrointestinal ecosystem is
similar to that found in human gastrointestinal tracts (Backhed
et al, 2004; Kibe et al, 2005). It is also significantly different
from conventional microbiota in terms of bacterial species and
relative composition, that is, higher levels of Enterobacteria
and Bacteroides (Table I). Our results show that significant
variations in microbial populations lead to modification of bile
acid symbiotic metabolism in the ileal lumen (Figures 3 and 5;
Table V). Furthermore, similar to HBF mice, re-conventiona-
lized mice also show elevated levels of Enterobacteria and
Bacteroides and high concentrations of TbMCA when com-
pared to conventional mice (Figure 5). The deconjugation of
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Figure 6 Effect of major bile acids on organ-specific metabolic profiles. O-PLS coefficient plots describing correlation between 1H NMR spectra of 1H MAS NMR CPMG
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Figure 7 Integration of bile acid and fecal flora correlations. The bipartite graphs were derived from correlations between fecal flora and bile acids in each group:
conventional (A) or HBF (B). G¼(N,E) specifies a graph G with N denoting the node set (bile acids) and E the edge set (correlation between bile acids, above a
defined cutoff, that is, |r|40.5), which was defined using network degree statistics (C). Bile acids and fecal bacteria correspond to blue ellipse nodes and green rectangle
nodes respectively. Edges are coded according to correlation value: positive and negative correlations are respectively displayed in blue and orange. aMA, a-muricholic
acid; Ba, Bacteroides; Bf, Bifidobacteria; bMA, b-muricholic acid; CA, cholic acid; CDCA, chenodeoxycholic acid; Cp, Clostridium perfringens; DCA,
deoxycholic acid; Eb, Enterobacteria; GCA, glycocholic acid; HCA, hyocholic acid; Lb, Lactobacillus; OMA, o-muricholic acid; Sc, Staphylococcus;
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ursocholic acid.
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bile acids involves the activity of bile salt hydrolase, which is
synthesized in significant amounts by Lactobacillus and
Bifidobacteria (De Smet et al, 1998). Alltogether, these
observations suggest that the balance between Lactobacillus
and Bifidobacteria and Enterobacteria, Bacteroides might be
essential in the deconjugation of TbMCA.
To investigate transgenomic metabolic interactions, we
show for the first time the use of bipartite graphs to display
correlation patterns between fecal flora and bile acids
(Figure 7). These graphs show the fine relationship between
specific gut microbial population modulation and bile acid
co-metabolism. For instance, the elevated concentrations
of TbMCA in HBF mice correspond to a relative inability of
HBF to deconjugate murine bile acids (Sacquet et al, 1984) and
to transform further TbMCA into derivatized bile acids, such
as u`MCA (Sacquet et al, 1979) or HCA (Eyssen et al, 1983)
(Figure 1 and Table V). The overwhelming contrast between
the simplicity of HBF mice and the complexity of conventional
mice bipartite networks (Figure 7) highlights the contrast
between the restrained abilities of the few bacterial strains
composing HBF to transform bile acids, on the one hand, and
the metabolic flexibility of conventional mice, on the other
hand, whereby the conventional murine bacterial strains
communicate with each other and disperse their metabolic
functions to synthesize additional bile acids (DCA, CDCA,
UDCA,oMCA, HCA, GCA, TDCA). In this regard, the synthesis
of oMCA appears as a good example as it can only be achieved
by specific bacterial strains (Sacquet et al, 1979) or through
bacterial cooperation (Eyssen et al, 1983). In this regard, this
lower complexity of the HBF bipartite network suggests lower
metabolic flexibility and robustness.
The potential role of microbiome in fat
emulsification and absorption
We observe a shift in the bile acid pattern towards tauro-
conjugates in HBF, which can be explained by a lower
deconjugation activity from the microbiota. Bile acids are
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Figure 8 Microbe–mammalian metabolic interactions related to bile acid and lipid metabolism. The bacterial reprocessing of the bile acid pool and regulation of bile
acid metabolism by bacterial SCFAs affect significantly the enterohepatic recirculation and the systemic lipid metabolism, that is, emulsification, absorption, transport of
dietary fats. The gut bacterial-induced regulation of enterohepatic recirculation also led to a physiological regulation of oxidative stress (glutathione), reprocessing of fatty
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amphiphilic (hydrophobic and hydrophilic) compounds and
conjugation modifies their hydrophobic/hydrophilic balance,
which directly relates to lipid emulsification and eventually
absorption (Armstrong and Carey, 1982; Heuman, 1989;
Heuman et al, 1989). Tauro-conjugation of bile acids reduces
the hydrophobic/hydrophilic ratio and increases their solubi-
lity and lipid emulsification. On the contrary, deconjugated
bile acids are less effective in emulsification of dietary lipids
and micelle formation (Armstrong and Carey, 1982; Heuman,
1989; Heuman et al, 1989; Narushima et al, 2000; Tannock,
2004). Here, we show that HBF mice have lower levels of CA
and higher levels of TCA and TbMCA (Figures 3 and 5), with
ratios of TCA:CA of 118.8 and TbMCA:bMCA of 52, whereas
conventional mice showed ratios of TCA:CA of 1.4 and
TbMCA:bMCA of 24 (Table V). These biochemical changes
towards increasing lipid emulsion efficiency of the bile acid
mixture (Staggers et al, 1982; Watkins, 1985) were also shown
to modify the hepatic phase II taurine conjugation activity as
described by the strong correlation between taurine concen-
tration in the liver and ileal bile acid composition (Figure 6).
This data integration clearly shows two opposite biological
mechanisms: the tauro-conjugation process of CA into TCA in
the liver, which is counterbalanced by a bacteria-mediated
deconjugation process in the intestinal tract (ileum). More-
over, HBF mice show higher urinary excretion of b-alanine,
which is a competitive inhibitor of taurine uptake in kidney
and liver as it shares the same transporter (Bollard et al, 2005).
The differences in b-alanine elimination also illustrate the
different requirements of taurine in the metabolism of bile
acids, which is consistent with higher demands in conven-
tional animals for conjugation of bile salts. Our observations
suggest increased hydrophilicity of the bile acid pool in HBF
and re-conventionalized mice, which would lead to higher
intestinal absorption of dietary lipids and higher enterohepatic
recycling of bile acid pool when compared to conventional
animals. Recent findings support our results with suggestion of
the essential microbial role in affecting bile acid-controlled
signaling pathways involved in energy and lipid metabolism
(Houten et al, 2006; Watanabe et al, 2006). In particular,
endogenous bile acids and derivates such as UDCA and
TUDCA were shown to be chemical chaperones (osmolytes)
with antidiabetic properties (Ozcan et al, 2006). Hence, the
perturbation of the microbiota by modifying bile acid
metabolism may ultimately affect the nutritional and wider
health status of the host.
The gut microbiota modulate lipid metabolism
in the host
The essential role of gut microbiota on serum lipid levels in
humans has gained interest recently, in relation to the possible
etiology of cardiovascular diseases (Pereira and Gibson, 2002).
For instance, cholesterol-lowering effects were reported for
Lactobacillus and Bifidobacteria, as well as protection against
VLDL and LDL oxidation (Terahara et al, 2000; Xiao et al,
2003). These observations are consistent with previous
findings that the microbiota promote storage of triglycerides
in adipocytes via indirect modulation of cellular fatty acids
uptake, secretion of apolipoproteins and adipocyte triglyceride
accumulation (Backhed et al, 2004; Dumas et al, 2006). Lin
et al (1996a, b) and Watanabe et al (2004) demonstrated that
an increase in the intracellular bile acids concentration (in
particular TCA) and decrease in hepatic bile acid synthesis
inhibit the synthesis and secretion of VLDL-associated
triglycerides from hepatocytes as well as the secretion of the
apolipoprotein associated with transport of VLDL, namely
apoB-100. These previous results indicate that bile acids might
play a physiological role in regulating VLDL production by the
liver, the enterohepatic circulation acting as a feedback loop.
This provides a mechanistic model in which the symbiotic
microbiota can modulate the host’s lipid metabolism. The gut
bacterial–mammalian metabolic interactions related to bile
acid and lipid metabolism are summarized in Figure 8.
A microflora nonadapted to mice modulates the
physiology of the host towards a pre-pathologic
state
In the present study, mice re-colonized with HBF show
decreased plasma lipoproteins concentration (mainly VLDL
and LDL), increased glycerol, GPC and choline in plasma and
increased hepatic triglyceride concentrations (Figure 3). Our
results suggest that the higher enterohepatic recycling of TCA
and TbMCA associated with higher intestinal absorption of
dietary lipids in HBF mice leads to reduced synthesis and
secretion of VLDL-associated triglycerides, and consequently
accumulation of lipids in the liver and reduction of VLDL and
LDL concentrations in plasma.
Such findings have to be interpreted simultaneously with
lower concentrations of glutathione observed in the liver from
HBF mice (Figure 3). Glutathione plays important roles in
nutrient metabolism and antioxidant defense: depletion in
glutathione contributes to oxidative stress, involved in the
pathogenesis of several diseases, including cancer, liver
disease, heart attack and diabetes (Wu et al, 2004). Previous
observations reported reduced glutathione levels in the liver of
rats fed with cholesterol plus cholic acid (Clarke et al, 1976;
Girard et al, 2005), which is consistent with the observed
higher intestinal absorption of dietary lipids and enterohepatic
recycling of bile acid pool in HBF mice. Reprocessing of fatty
acids and subsequent generation of radical oxidative species
result in higher oxidative stress, this situation leading
to peroxidation of hepatic lipids and eventually liver disease
(Wu et al, 2004). Such glutathione depletion can be reached
either by nutritional deficiency or by increased glutathione
peroxidase and glutathione reductase activities in tissues. High
oxidative stress denotes an increased lipoperoxidation risk
(Figure 8). Altogether, our observations suggest that HBF is not
a sustainable flora for mice, which might result in impaired
liver functions.
In conclusion, both systemic and tissue-specific metabolic
changes across a wide range of metabolic pathways and
metabolite classes indicate the deep extent of host–microbiota
co-metabolic interactions. This work strongly supports the
idea that several complex metabolic disease traits can be
influenced by the gut microbiota.
In this study, we have shown that re-conventionalization of
mice normalizes their metabolism towards a healthy physiol-
ogy. This metabolic convergence strikingly contrasts with our
observations in the HBF model. We report that HBF is not a
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sustainable flora for mice, which modifies the physiology of
the murine host towards a pre-pathologic state. Whereas re-
conventionalized mice evolve to normal gut flora from an
ecological point of view, HBF supplementation maintains the
gut tract and the liver out of a sustainable mouse ecological
equilibrium, as denoted by higher numbers of Clostridium
perfringens (Table I). The metabolic consequences for the host
show an increase in lipid accumulation in liver (despite a
decrease in lipoprotein sub-fractions in blood) associated to a
higher lipoperoxidation risk. We also observed the critical
involvement of the microbiome in supplying host calorific
requirement via caloric recovery through fibers fermentation.
In this case, gut bacteria exert modulation over the host
metabolism via reprocessing of signaling molecules, that is,
bile acids, that might be involved in common metabolic
diseases such as obesity or type II diabetes (Houten et al, 2006;
Ozcan et al, 2006; Watanabe et al, 2006). As such, bile acids
may be an example of transgenomic mechanism of quorum
sensing (Nicholson et al, 2005), whereby microbial cells
communicate with each other and disperse their metabolic
functions, thus behaving like a multicellular organism.
Metabolic profiling on conventional mice, compared to HBF
animals, showed that the gut microflora are an essential
evolutionary driver towards providing more refined control
mechanisms on the host’s physiology, which ultimately
determine host nutritional status and health. Our results
suggest that controlling the dynamics of the gut microbiome to
maintain or re-establish a balanced and well-adapted micro-
flora could help to prevent some microbial-related metabolic
disorders such as hepato-gastrointestinal diseases.
Materials and methods
Animal handling procedure and probiotic
administration
All animal studies were carried out under appropriate national
guidelines at the Nestle´ Research Center (Lausanne, Switzerland).
The HBF strains were isolated from stool from a 20-day-old female
baby, who was naturally delivered and breast-fed as described
previously (Guigoz et al, 2002). The HBF flora contained only the
following strains of bacteria: E. coli, Bifidobacteria breve, B. longum,
Staphylococcus epidermidis, S. aureus, C. perfringens and Bacteroides.
After 48 h at 371C (24 h for E. coli, S. aureus and S. epidermidis), the
number of bacteria for each strain was estimated as described
previously (Guigoz et al, 2002) and were mixed at equal amounts
(1010 cells/ml for each strain) for gavage. Bacterial cell mixtures for
inoculation were kept in frozen aliquots with their spent culture
medium until use. L. paracasei was obtained from the Nestle´ Culture
Collection (Lausanne, Switzerland) and grown under anaerobic
conditions in Man-Rogosa-Sharpe (MRS) culture medium.
A total of 26 C3H female mice, aged 6 weeks, were fed with a
standard pathogen-free rodent diet (Nestle´, Switzerland). A group of
conventional mice was kept as control (n¼9). One group of germfree
mice was re-conventionalized by removal from their germfree isolator
and exposure to normal environment for a period of 4 weeks (n¼10). A
second group of germfree mice received a single dose of HBF (n¼7) by
oral gavage and 2 weeks later, they were given L. paracasei probiotic by
mixing aliquots of 1 ml probiotics (4109 cells/ml) with 200 ml of
saline under pathogen-free conditions for a period of 2 weeks. As each
mouse drinks on average 5 ml/day, each mouse received around 108
probiotic bacteria per day, which allows maintaining the probiotic
population in a steady state within the gut environment. Animals were
euthanized after 4 weeks and microbial analysis was carried out on
fecal samples as described previously (Guigoz et al, 2002). Urine was
collected from mice before killing upon holding them by immobiliza-
tion grip and urine was snap-frozen immediately. Blood (400 ml) was
collected into Li-heparin tubes and the plasma was obtained after
centrifugation and frozen at 701C. The liver was dissected and snap-
frozen. The intestine from the stomach to the cecum was removed
from each animal. The first 1 cm length after the stomach was
considered to be duodenum and the rest was divided into three
sections: the first 2/3 was designated as jejunum and the remaining
1/3 as ileum. Three-centimeter samples (3 cm) were excised from the
middle of each section. Ileal flush samples were obtained by rinsing
the ileal lumen with 1 ml of a phosphate buffer solution (0.2 M
Na2HPO4/0.04 M NaH2PO4 (pH 7.4)) using a 1-ml sterile syringe.
Samples were retrieved in Eppendorf tubes and snap-frozen before
NMR spectroscopy and UPLC–MS analyses. Samples included five
flush samples from conventional and re-conventionalized mice and
seven flush samples from HBF colonized mice. Cecal content was
collected upon animal autopsy, snap-frozen immediately and kept at
801C before analysis.
Microbial profiling of fecal contents
Briefly, for each mouse, one fecal pellet was homogenized in 0.5 ml
Ringer solution (Oxoid, UK) supplemented with 0.05% (w/v)
L-cysteine (HCl), and different dilution of the bacterial solution were
plated on selective and semiselective media for the enumeration of
specific microorganisms: Bifidobacteria on Eugom Tomato medium,
Lactobacillus on Man, Rogosa and Sharpe (MRS)þ antibiotics
(phosphomycine, sulfamethoxazole and trimethoprime) medium,
C. perfringens on NN-agar medium, Enterobacteriaceae on Drigalski
medium and Bacteroides on Shaedler Neo Vanco medium (Guigoz
et al, 2002). Plates were incubated at 371C under aerobic conditions for
24 h for the counting of Enterobacteriaceae, and under anaerobic
conditions during 48 h for Bifidobacteria, Lactobacillus, Bacteroides
and C. perfringens.
Gas chromatography analysis of cecal contents
Fecal SCFAs in cecum were analyzed using gas chromatography flame-
ionization-detection (GC-FID). An aliquot of cecal content was
extracted with 4 ml buffer (0.1% (w/v) HgCl2 and 1% (v/v) H3PO4)
supplemented with 0.045 mg/ml 2,2-dimethylbutyric acid (as internal
standard) per gram fresh weight. The resulting slurry was centrifuged
for 30 min at 5000 g at 41C, and the SCFAs in the supernatant collected
were analyzed using a GC (HP 6890) equipped with flame ionization
detector (FID) and a DB-FFAP column (J&W Scientific, MSP Friedli and
Co., Switzerland) of 30 m length, 530mm diameter and 1 mm film
thickness. The system was run with helium gas at an inlet constant
pressure of 10 psi at 1801C. Each sample run was preceded with a
cleaning injection of 1.2% formic acid. Samples were run at an initial
temperature of 801C for 1.2 min, then at 1451C for 6.5 min, at 2001C for
0.55 min and at 2001C for 0.5 min. SCFAs were identified using external
standards consisting of authentic acetate, propionate, iso-butyrate,
n-butyrate, iso-valerate and n-valerate, and the concentration was
calculated using internal standard.
1H NMR spectroscopic analysis
Plasma samples were prepared by adding saline solution containing
10% D2O (serving as a spectrometer field frequency lock) into 100 ml of
blood plasma to a total volume of 550 ml. Urine samples were prepared
by mixing 20ml of samples with 30ml of a deuterated phosphate buffer
solution (90% D2O, 10% H2O) containing 0.25 mM 3-trimethylsilyl-1-
[2,2,3,3-2H4] propionate (TSP) as chemical shift reference (d 0.0). Ileal
flushes were sonicated at ambient temperature (298 K) for 30 min to
destroy bacterial cells and then centrifuged at 13 000 r.p.m. for 15 min.
Aliquots of 300ml were mixed with 300 ml of a solution containing 90%
D2O and 0.25 mM TSP. Intact liver samples were bathed in 0.9% saline
D2O solution. A portion of the tissue (B15 mg) was inserted into a
zirconium oxide 4 mm outer diameter rotor, using an insert to make
a spherical sample volume of 25ml.
All 1H NMR spectra were recorded on a Bruker DRX 600 NMR
spectrometer (Rheinstetten, Germany) operating at 600.11 MHz for 1H
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observation. 1H NMR spectra of plasma, urine and ileal flushes were
acquired with a Bruker 5 mm TXI triple resonance probe at 298 K. 1H
NMR spectra of intact liver tissues were acquired under magic-angle-
spinning conditions at a spin rate of 5000 Hz (Waters et al, 2000).
Tissue samples were regulated at 283 K using cold N2 gas during the
acquisition of the spectra to minimize any time-dependent biochem-
ical degradation.
1D 1H NMR spectra were obtained from each sample using a
standard solvent suppression pulse sequence (RD-901-t1-901-tm-901-
acquire FID) with tm fixed at 100 ms and t1 at 3ms (Wang et al, 2005).
Additional 1D Carr-Purcell-Meiboom-Gill (CPMG) spectra were
acquired for plasma and liver samples. CPMG spectra were acquired
using the pulse sequence (RD-901-(t-1801-t)n-acquire FID), with a
spin–spin relaxation delay, 2nt, of 160 ms for plasma and 200 ms for
tissue (Stejskal and Tanner, 1965). The 901 pulse length was 9.0–12 ms.
A total of 128 transients were collected into 32 K data points with a
pulse recycle delay (RD) of 2 s.
For assignment purposes, 2D COSY (Nagayama, 1980) and TOCSY
(Bax and Davis, 1985) NMR spectra were acquired on selected
samples. Further assignment of the metabolites was also accomplished
with the use of STOCSY on 1D spectra (Cloarec et al, 2005a).
UPLC–MS materials and methods
The UPLC of ileal flushes was performed on a ACQUITY UPLCt system
(Waters, Milford, MA, USA). Mass Spectrometry was performed on a
TOFt LCT-Premier (Waters MS Technologies, Manchester, UK). Flush
samples were first freeze-dried before being diluted to a final
concentration of 1 mg/ml with a 1:1 acetonitrile/water solution.
Samples were maintained at 41C, and 10 and 1ml injections were made
into a 10 cm 2.1 mm ACQUITYt BEH C18 1.7mm UPLC column
(Waters) maintained in an oven at 401C. The bile acids eluted under
gradient conditions at a flow rate of 500 ml/min from aceto-
nitrile:water¼40:60 to 60:40 over 12 min (pH 4).
The Q-TOF mass spectrometer was operated in W-optic path and
negative ion mode with a capillary voltage of 2.6 kV, cone voltage of
50 V, nebulizer gas flow of 600 l/h, desolvation temperature of 3001C
and a source temperature of 1001C. All analyses were acquired using
the lock-spray to ensure mass accuracy and reproducibility, and
leucine-enkephalin was used as the lock mass (m/z 554.2615) at a
concentration of 200 ng/ml and a flow rate of 20ml/min. Data were
collected over 12 min in centroid mode with a lock-spray frequency of
11 s over the mass range m/z 50–850 with an acquisition time
of 250 ms, an interscan delay of 50 ms and data averaging over 10 scans.
The standards used as bile acid reference materials are listed in
Figure 4 with the abbreviations, molecular structure, molecular weight
and the retention time observed using this UPLC–MS method.
Data preparation
1H NMR spectra were manually phased and baseline-corrected using
XwinNMR 3.5 (Bruker Biospin, Rheinstetten, Germany) and referenced
to the chemical shift of the CH3 resonance of alanine at d 1.466. The
regions containing the water resonance (d 4.5–5.19), and for urine urea
resonance (d 4.5–6.2), were removed. The spectra were converted into
22 K data points over the range of d 0.2–10.0 using an in-house-developed
MATLAB routine (Dr O Cloarec, personal communication). The spectra
were normalized to a constant sum before chemometric analyses.
UPLC–MS data were processed using the Micromass MarkerLynxt
applications manager Version 4.0 (Waters). The peaks of bile acids
were identified by comparison to the m/z ratio and retention time of a
set of standard bile acids (Figure 4). Integration of the UPLC–MS bile
acid peaks was performed using ApexTrack2t peak detection
(Waters). Data were noise-reduced in both the UPLC and MS domains
using MarkerLynxt. The ion intensities for each bile acid identified
were normalized, within each sample, to the sum of the peak
intensities in that sample.
Chemometrics: modeling and interpretation
Statistical analysis of the changes in bacterial populations and in the
fecal composition in SCFAs obtained by GC-FID was carried out using a
two-tailed Mann–Whitney test.
The multivariate pattern recognition techniques used in this study
were based on orthogonal projection to latent structure (O-PLS)
approach with unit-variance scaling (Trygg and Wold, 2003). In O-PLS-
DA algorithm, the variation in X (NMR spectra or ion counts) is
decomposed into three parts: first, the variation in X (the data matrix)
related to Y (the class matrix), and the two last parts contain the
specific systemic variation in X and residual, respectively (Trygg and
Wold, 2003). This leads to a model with a minimal number of
predictive components defined by the number of degrees of freedom
between group variances. The O-PLS coefficient (covariance) plots are
presented using a back-scaling transformation, which preserves the
original spectral structure appearance for NMR data (Cloarec et al,
2005b). This also allows each data variable to be plotted with a color
code, which relates to the significance of class discrimination as
calculated from the correlation matrix. The covariance and correlation
correspond to the shape and color code respectively. Here, a coefficient
of r¼0.57 was determined according to the test for the significance of
the Pearson’s product-moment correlation coefficient as the cutoff
value, which was calculated based on discrimination significance at
the level of Po0.05. The standard seven-fold cross-validation method
was applied to establish the robustness of the model (Holmes et al,
2006).
Bipartite graph representation bile acid and fecal
flora profiles
To explore the possible transgenomic interactions between gut
microbes and the host’s metabolism, functional correlation networks
were derived from bile acid and fecal flora profiles correlation
coefficients using the bipartite graph Rgraphsviz package from R to
represent the correlation matrix. Pearson’s correlation coefficients
were computed between bile acid variables and fecal flora variables
from the same animals. A cutoff was then applied to the absolute value
of the coefficient |r|, so that absolute correlations |r|4cutoff were set
to 1 and absolute correlations |r|ocutoff were set to 0, thus defining
the adjacency matrix for the graph (defining connections between
entities). Hence, G¼(N, E) specifies a graph G with N denoting the two
node sets (two types of nodes: bile acids and fecal flora) and E the edge
set (link between nodes, here a correlation between bile acids and fecal
flora above the cutoff, i.e. |r|40.5). The bipartite graph represents
only the correlations between the two types of nodes (fecal flora and
bile acids). In that context, presence of edges between two specific
nodes (one of each type) reveals a functional correlation (above the
cutoff) between these two entities. On the graph, the edges were then
color-coded to represent the sign of the initial correlation (blue
negative, orange positive) and the correlation value was displayed. To
assess the pattern of correlations between fecal flora and bile acids,
several correlation cutoff values were tested. For each correlation
cutoff value, the number of edges connected to each was then
computed to assess the degree of the network (number of edges
connected to the most connected node).
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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